我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
13
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
1
7.7%
已完成
9
69.2%
尚未招募
招募中
暂停
暂无批准数据
- The FDA acknowledged OmniActive's Lutemax Free Lutein for use in infant formula through GRAS clearance, marking a significant regulatory milestone for early life nutrition. - Lutein is one of the most abundant carotenoids in breast milk, and this clearance allows infant formula to come closer to breast milk composition. - The ingredient helps bridge nutritional gaps for formula-fed infants who cannot produce lutein on their own, supporting critical brain and eye development during the first year of life. - This approval opens an entirely new category for OmniActive and validates over 20 years of research into the lifelong benefits of the Lutemax portfolio.
